MedPath

ProCertus BioPharm, Inc.

ProCertus BioPharm, Inc. logo
🇺🇸United States
Ownership
Private
Established
1997-01-01
Employees
1
Market Cap
-
Website
http://www.procertus.com

Exploratory Study of Topical Norepinephrine in Breast Cancer Patients Receiving Radiotherapy

Phase 1
Withdrawn
Conditions
Radiodermatitis
Interventions
First Posted Date
2012-03-06
Last Posted Date
2012-05-28
Lead Sponsor
ProCertus BioPharm, Inc
Registration Number
NCT01544504
Locations
🇺🇸

H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Exploratory Study of Norepinephrine to Prevent Alopecia in Head and Neck Cancer Patients Treated With Radiotherapy

Phase 1
Terminated
Conditions
Alopecia
Radiodermatitis
Interventions
First Posted Date
2011-06-07
Last Posted Date
2012-03-23
Lead Sponsor
ProCertus BioPharm, Inc
Target Recruit Count
3
Registration Number
NCT01367990
Locations
🇺🇸

H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Exploratory Study of Norepinephrine to Prevent Radiodermatitis in Breast Cancer Patients

Phase 1
Terminated
Conditions
Radiodermatitis
Interventions
First Posted Date
2010-12-20
Last Posted Date
2013-04-19
Lead Sponsor
ProCertus BioPharm, Inc
Target Recruit Count
10
Registration Number
NCT01263366
Locations
🇺🇸

University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath